NO953967L - Indolderivater som 5-HT1A og/eller 5-HT2 ligander - Google Patents

Indolderivater som 5-HT1A og/eller 5-HT2 ligander

Info

Publication number
NO953967L
NO953967L NO953967A NO953967A NO953967L NO 953967 L NO953967 L NO 953967L NO 953967 A NO953967 A NO 953967A NO 953967 A NO953967 A NO 953967A NO 953967 L NO953967 L NO 953967L
Authority
NO
Norway
Prior art keywords
indole derivatives
ht1a
ligands
derivatives
processes
Prior art date
Application number
NO953967A
Other languages
English (en)
Other versions
NO953967D0 (no
Inventor
Myrna Gil Quintero
Vincenzo Martino
Franco Borsini
Carlo Maria Pellegrini
Marco Turconi
Ettore Giraldo
Original Assignee
Boehringer Ingelheim Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Italia filed Critical Boehringer Ingelheim Italia
Publication of NO953967D0 publication Critical patent/NO953967D0/no
Publication of NO953967L publication Critical patent/NO953967L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)

Abstract

Farmakologisk, aktive indolderivater med sentral- serotonergisk aktivitet og som kan brukes for behandling av lidelser som angår det sentrale nervesystem, med formel (I)hvor R, R! og R2 er som beskrevet i foreliggende beskrivelse, fremgangsmåter for deres fremstilling og farmasøytiske preparater som inneholder slike derivater.
NO953967A 1993-04-08 1995-10-05 Indolderivater som 5-HT1A og/eller 5-HT2 ligander NO953967L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI930699A IT1271352B (it) 1993-04-08 1993-04-08 Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale
PCT/EP1994/001016 WO1994024125A1 (en) 1993-04-08 1994-03-31 Indole derivatives as 5-ht1a and/or 5-ht2 ligands

Publications (2)

Publication Number Publication Date
NO953967D0 NO953967D0 (no) 1995-10-05
NO953967L true NO953967L (no) 1995-12-05

Family

ID=11365694

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953967A NO953967L (no) 1993-04-08 1995-10-05 Indolderivater som 5-HT1A og/eller 5-HT2 ligander

Country Status (20)

Country Link
US (1) US5834493A (no)
EP (1) EP0694033A1 (no)
JP (1) JPH08508738A (no)
CN (1) CN1124960A (no)
AU (1) AU684276B2 (no)
BG (1) BG100040A (no)
BR (1) BR9406206A (no)
CA (1) CA2160020A1 (no)
CZ (1) CZ283398B6 (no)
FI (1) FI954734L (no)
HU (1) HUT74090A (no)
IL (1) IL109234A (no)
IT (1) IT1271352B (no)
NO (1) NO953967L (no)
NZ (1) NZ265055A (no)
PL (1) PL310995A1 (no)
SG (1) SG50507A1 (no)
SK (1) SK119795A3 (no)
WO (1) WO1994024125A1 (no)
ZA (1) ZA942383B (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420521D0 (en) * 1994-10-12 1994-11-30 Smithkline Beecham Plc Novel compounds
CA2288334C (en) * 1997-05-09 2005-03-01 H. Lundbeck A/S Method of manufacturing sertindole
US6673827B1 (en) 1999-06-29 2004-01-06 The Uab Research Foundation Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
JP2002509149A (ja) 1998-01-14 2002-03-26 ザ ユーエイビー リサーチ ファウンデイション 細菌ｎａｄシンテターゼ酵素の阻害剤の合成およびスクリーニング方法、その化合物、ならびに細菌ｎａｄシンテターゼ酵素の阻害剤を用いる細菌および微生物感染の治療方法
US6861448B2 (en) * 1998-01-14 2005-03-01 Virtual Drug Development, Inc. NAD synthetase inhibitors and uses thereof
US6133287A (en) * 1998-03-24 2000-10-17 Allelix Biopharmaceuticals Inc. Piperidine-indole compounds having 5-HT6 affinity
CN1160332C (zh) * 1998-04-08 2004-08-04 惠氏公司 用于治疗抑郁症的n-芳氧基乙基胺衍生物
AU3765899A (en) * 1998-04-29 1999-11-16 American Home Products Corporation Serotonergic agents
FR2799463B1 (fr) * 1999-10-12 2004-04-16 Adir Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent
DE19951360A1 (de) * 1999-10-26 2001-05-03 Aventis Pharma Gmbh Substituierte Indole
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
MXPA03005433A (es) 2000-12-22 2003-09-10 Wyeth Corp Compuestos de heterociclilalquilindol o-azaindol como ligandos de 5-hidroxitriptamina-6.
US7135479B2 (en) 2002-09-12 2006-11-14 Wyeth Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
RU2591194C2 (ru) * 2010-04-22 2016-07-10 Интра-Селлулар Терапиз, Инк. Органические соединения
JP2015514135A (ja) 2012-04-14 2015-05-18 イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． 新規組成物および方法
DK2968320T3 (da) 2013-03-15 2021-02-01 Intra Cellular Therapies Inc Organiske forbindelser
CA3148303C (en) 2013-12-03 2024-02-27 Intra-Cellular Therapies, Inc. Heterocycle fused gamma-carboline compounds for use in treatment of bipolar disorders
CA2944512C (en) 2014-04-04 2018-04-24 Intra-Cellular Therapies, Inc. Heterocycle fused gamma-carbolines for treatment of central nervous system disorders
CA2944755A1 (en) 2014-04-04 2015-10-08 Intra-Cellular Therapies, Inc. Organic compounds
WO2017023894A1 (en) * 2015-08-03 2017-02-09 Raze Therapeutics, Inc. Mthfd2 inhibitors and uses thereof
PT3407888T (pt) 2016-01-26 2021-03-19 Intra Cellular Therapies Inc Compostos de piridopirroloquinoxalina, suas composições e utilizações
SI3407889T1 (sl) 2016-03-25 2021-09-30 Intra-Cellular Therapies, Inc. Organske spojine in njihova uporaba v zdravljenju ali preprečevanju motenj centralnega živčnega sistema
US10682354B2 (en) 2016-03-28 2020-06-16 Intra-Cellular Therapies, Inc. Compositions and methods
JP7013454B2 (ja) 2016-10-12 2022-02-15 イントラ－セルラー・セラピーズ・インコーポレイテッド アモルファス固体分散体
WO2018126140A1 (en) 2016-12-29 2018-07-05 Intra-Cellular Therapies, Inc. Organic compounds
WO2018126143A1 (en) 2016-12-29 2018-07-05 Intra-Cellular Therapies, Inc. Organic compounds
IL304026B2 (en) 2017-03-24 2024-11-01 Intra Cellular Therapies Inc A pharmaceutical preparation containing 1-(4-fluoro-phenyl)-4-((Sa10,Rb6)-3-D2-2,2-methyl-2, 3, a10, 10, 9, b6- hexahydro-H7, H1- Pyrido[3',4',:4,5]pyrrolo[3,2,1-de]quioxalin-8-yl)-butan-1-one and its uses
US11427587B2 (en) 2017-07-26 2022-08-30 Intra-Cellular Therapies, Inc. Organic compounds
JP7223742B2 (ja) 2017-07-26 2023-02-16 イントラ－セルラー・セラピーズ・インコーポレイテッド 有機化合物
IL277504B1 (en) 2018-03-23 2026-02-01 Intra Cellular Therapies Inc Deuterium-converted ((sa10,rb6)-8-(3-(4-fluorophenoxy)propyl 6b, 7, 8, 9, 10, 10a-hexahydro-1h-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-82(h3)-one compounds, pharmaceutical composition containing them and their uses
WO2019237037A1 (en) 2018-06-08 2019-12-12 Intra-Cellular Therapies, Inc. Novel methods
US12144808B2 (en) 2018-08-29 2024-11-19 Intra-Cellular Therapies, Inc. Compositions and methods
AU2019328528B2 (en) 2018-08-31 2025-01-23 Intra-Cellular Therapies, Inc. Novel methods
MX2021002321A (es) 2018-08-31 2021-04-28 Intra Cellular Therapies Inc Nuevos metodos.
CN114072150A (zh) 2019-07-07 2022-02-18 细胞内治疗公司 新方法
US12414948B2 (en) 2022-05-18 2025-09-16 Intra-Cellular Therapies, Inc. Methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
CA2091562C (en) * 1990-10-15 2001-03-27 John Eugene Macor Indole derivatives useful in psychotherapeutics
JP3140155B2 (ja) * 1992-03-09 2001-03-05 杏林製薬株式会社 Ｎ，ｎ’−ジ置換アミド誘導体
TW226019B (no) * 1992-03-23 1994-07-01 Sankyo Co

Also Published As

Publication number Publication date
IT1271352B (it) 1997-05-27
CN1124960A (zh) 1996-06-19
CA2160020A1 (en) 1994-10-27
PL310995A1 (en) 1996-01-22
SG50507A1 (en) 1998-07-20
EP0694033A1 (en) 1996-01-31
FI954734A0 (fi) 1995-10-05
ITMI930699A0 (it) 1993-04-08
JPH08508738A (ja) 1996-09-17
FI954734A7 (fi) 1995-10-05
SK119795A3 (en) 1996-04-03
HU9502913D0 (en) 1995-11-28
ZA942383B (en) 1995-10-09
BG100040A (bg) 1996-03-29
BR9406206A (pt) 1996-02-06
HUT74090A (en) 1996-11-28
AU6538294A (en) 1994-11-08
US5834493A (en) 1998-11-10
IL109234A0 (en) 1994-07-31
NO953967D0 (no) 1995-10-05
IL109234A (en) 1998-04-05
WO1994024125A1 (en) 1994-10-27
NZ265055A (en) 1996-09-25
FI954734L (fi) 1995-10-05
AU684276B2 (en) 1997-12-11
CZ283398B6 (cs) 1998-04-15
CZ260295A3 (en) 1996-01-17
ITMI930699A1 (it) 1994-10-08

Similar Documents

Publication Publication Date Title
NO961687D0 (no) Nye (R)-5-karbamoyl-8-fluor-3-N,N-disubstituerte-amino-3,4-dihydro-2H-1-benzopyraner
CA2148928A1 (en) Pharmacologically active pyridine derivatives and processes for the preparation thereof
NO883229L (no) Nye benzimidazolderivater, fremgangsmaate for deres fremstilling og farmasoeytisk preparat inneholdende slike derivater.
IL104006A0 (en) Azaheterocyclylmethyl-chromans,their preparation and pharmaceutical compositions containing them
CA2012876A1 (en) Use of 5-methyltetrahydrofolic acid and 5-formyltetrahydrofolic acid in the treatment of organic mental disturbances
CA2086434A1 (en) Quinuclidine derivatives
WO2002024701A3 (en) Substituted azepino[4,5b)indole derivatives
GEP20033140B (en) Substituted Bicyclic Derivatives Useful as Anticancer Agents
CA2296313A1 (en) 2-aminopyridines containing fused ring substituents as nos inhibitors
HUT61543A (en) Process for producing serotonin antagonist indole derivatives and pharmaceutical compositions comprising same as active ingredient
RU94038064A (ru) Производные пиперазина и пиперидина, их применение в качестве противопсихотических средств, способ их получения фармацевтическая композиция
IL94433A0 (en) Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
AP9701019A0 (en) Phenylamino-substituted tricycle derivatives.
DE69523155D1 (de) Benzimidazolonderivate mit zentraler dopaminerger aktivität
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
DK0825197T3 (da) Nye 6-hydroxy- og 6-oxo-androstanderivater, der er aktive i forhold til det cardiovaskulære system, og farmaceutiske præpar
RU94039284A (ru) Производные пиперазина, способ их получения, фармкомпозиция и ее использование
ATE242220T1 (de) Benzimidazolderivate mit dopaminerger wirkung
AU581855B2 (en) 1-(4'-alkylsulphonylphenyl)-2-amino-1, 3-propanediol n-substituted derivatives
ATE229953T1 (de) Naphtho-imidazo(1,2-a)pyridin derivate, deren herstellung und deren verwendung in der behandlung von störungen des zentralnervensystems
DK176390D0 (da) Pyrazindiazohydroxidforbindelser
UA27738C2 (uk) 2,3,4,5,6,7-гексагідро-1-[4-[1-[4-(2метоксифеніл)піперазиніл]]-2-фенілбутирил]-1н-азепін або його фармацевтично прийнятна кислотно-адитивна сіль, що мають властивість пов'язувати рецептор 5нт1а, спосіб (варіанти) їх одержання, фармацевтична композиція
GEP19980890B (en) Derivatives of N1-(1,2-Cis-halogeno¬-cyclopropyl) Substituted Pyridonecarbonic Acid
NO970498L (no) Benzimidazolderivater med dopaminergisk aktivitet